Report - Capital Market Day 2012 - Homepage - Fresenius · Global Injectable Generics Market Source: IMS MAT Dec 2011, IV Generics, excluding Enoxaparin, excluding Japan Key Competitors 10%

Please pass captcha verification before submit form